Radiation Oncology/Therapy: Page 225

Reirradiation of brain metastases offers limited help

By AuntMinnie.com staff writers

Cancer patients with brain metastases that recur after initial radiotherapy don't have long to live. Is reirradiation worthwhile? A study published online February 9 in the Japanese Journal of Clinical Oncology determined that this treatment extended life only by several months and caused a high level of lethargy.

March 2, 2012

Imaging and therapy specialists combine to combat rectal cancer

By Cynthia E. Keen

VIENNA - The odds are unpleasantly high that a rectal cancer diagnosis will be a death sentence. Advanced imaging techniques, however, are offering new hope to both low-risk and high-risk patients. Radiologists collaborating with radiation oncologists have the potential to make a world of difference for these patients.

March 1, 2012

Elekta wins Australian VMAT contract

By AuntMinnie.com staff writers

Oncology firm Elekta has installed its volumetric modulated arc therapy (VMAT) and Integrity digital control system at an Australian cancer clinic.

March 1, 2012

Irish students excel in radiation prevention education program

By Wayne Forrest

Undergraduate students at University Cork College in the Republic of Ireland are learning a valuable lesson in radiation protection thanks to a new program at the school, which is detailed in the March issue of the Journal of the American College of Radiology.

February 29, 2012

Pancreatic cancer management demands teamwork, multidisciplinary approach

By Frances Rylands-Monk

VIENNA - Management and treatment of pancreatic cancer patients is a complex and challenging task requiring a multilateral effort across medical specialties. Speakers at today's session intend to illustrate a unified approach to pancreatic cancer that enables the goals of each specialty to be achieved for timely diagnosis and effective treatment.

February 29, 2012

Varian nets FDA OK for transponder

By AuntMinnie.com staff writers

Radiation therapy firm Varian Medical Systems has received 510(k) clearance from the U.S. Food and Drug Administration for a surface beacon transponder for its Varian Calypso system as a real-time tracking device to monitor motion during radiotherapy for indications anywhere in the body.

February 27, 2012